These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 2785570

  • 1. Distinct restriction of complement- and cell-mediated lysis.
    Hollander N, Shin ML, Rosse WF, Springer TA.
    J Immunol; 1989 Jun 01; 142(11):3913-6. PubMed ID: 2785570
    [Abstract] [Full Text] [Related]

  • 2. Resistance of cytolytic lymphocytes to perforin-mediated killing. Murine cytotoxic T lymphocytes and human natural killer cells do not contain functional soluble homologous restriction factor or other specific soluble protective factors.
    Jiang S, Persechini PM, Perussia B, Young JD.
    J Immunol; 1989 Sep 01; 143(5):1453-60. PubMed ID: 2503557
    [Abstract] [Full Text] [Related]

  • 3. Structural/functional similarity between proteins involved in complement- and cytotoxic T-lymphocyte-mediated cytolysis.
    Tschopp J, Masson D, Stanley KK.
    Nature; 1989 Sep 01; 322(6082):831-4. PubMed ID: 2427956
    [Abstract] [Full Text] [Related]

  • 4. Synergistic inhibition of human cell-mediated cytotoxicity by complement component antisera indicates that target cell lysis may result from an enzymatic cascade involving granzymes and perforin.
    Brahmi Z, Csipo I, Bochan MR, Su B, Montel AH, Morse PA.
    Nat Immun; 1995 Sep 01; 14(5-6):271-85. PubMed ID: 8933821
    [Abstract] [Full Text] [Related]

  • 5. Absence of homologous restriction factor does not affect CTL-mediated cytolysis.
    Krähenbühl OP, Peter HH, Tschopp J.
    Eur J Immunol; 1989 Jan 01; 19(1):217-9. PubMed ID: 2784107
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Homologous species restriction of the complement-mediated killing of nucleated cells.
    Yamamoto H, Blaas P, Nicholson-Weller A, Hänsch GM.
    Immunology; 1990 Aug 01; 70(4):422-6. PubMed ID: 1697561
    [Abstract] [Full Text] [Related]

  • 10. Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis.
    Gorter A, Blok VT, Haasnoot WH, Ensink NG, Daha MR, Fleuren GJ.
    Lab Invest; 1996 Jun 01; 74(6):1039-49. PubMed ID: 8667608
    [Abstract] [Full Text] [Related]

  • 11. Complement lysis of U937, a nucleated mammalian cell line in the absence of C9: effect of C9 on C5b-8 mediated cell lysis.
    Morgan BP, Imagawa DK, Dankert JR, Ramm LE.
    J Immunol; 1986 May 01; 136(9):3402-6. PubMed ID: 3514758
    [Abstract] [Full Text] [Related]

  • 12. Enhanced expression of the complement-regulatory factor C8 binding protein (C8bp) on U937 cells after stimulation with IL-1 beta, endotoxin, IFN-gamma, or phorbol ester.
    Schieren G, Janssen O, Hänsch GM.
    J Immunol; 1992 May 15; 148(10):3183-8. PubMed ID: 1578143
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Protection of porcine aortic endothelial cells from complement-mediated cell lysis and activation by recombinant human CD59.
    Kennedy SP, Rollins SA, Burton WV, Sims PJ, Bothwell AL, Squinto SP, Zavoico GB.
    Transplantation; 1994 May 27; 57(10):1494-501. PubMed ID: 7515200
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The C8-binding protein of human erythrocytes: interaction with the components of the complement-attack phase.
    Schönermark S, Filsinger S, Berger B, Hänsch GM.
    Immunology; 1988 Apr 27; 63(4):585-90. PubMed ID: 3366469
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.
    Neville ME, Hiserodt JC.
    J Immunol; 1982 Mar 27; 128(3):1246-51. PubMed ID: 6976989
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Expression of complement membrane regulators membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59) in human malignant gliomas.
    Mäenpää A, Junnikkala S, Hakulinen J, Timonen T, Meri S.
    Am J Pathol; 1996 Apr 27; 148(4):1139-52. PubMed ID: 8644856
    [Abstract] [Full Text] [Related]

  • 20. Isolation of homologous restriction factor from human urine. Immunochemical properties and biologic activity.
    Zalman LS, Brothers MA, Müller-Eberhard HJ.
    J Immunol; 1989 Sep 15; 143(6):1943-7. PubMed ID: 2476489
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.